This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This PTPRCAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 90-118 amino acids from the Central region of human PTPRCAP.
PTPRCAP
Reaktivität: Human
WB, EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.48 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
PTPRCAP
(Protein tyrosine Phosphatase, Receptor Type, C Polypeptide-Associated Protein (PTPRCAP))
AI605264 antikoerper, CD-45-AP antikoerper, LPAP antikoerper, LSM-1 antikoerper, CD45-AP antikoerper, protein tyrosine phosphatase, receptor type, C polypeptide-associated protein antikoerper, protein tyrosine phosphatase, receptor type C associated protein antikoerper, protein tyrosine phosphatase, receptor type, C-associated protein antikoerper, Ptprcap antikoerper, PTPRCAP antikoerper
Hintergrund
The protein encoded by this gene was identified as a transmembrane phosphoprotein specifically associated with tyrosine phosphatase PTPRC/CD45, a key regulator of T- and B-lymphocyte activation. The interaction with PTPRC may be required for the stable expression of this protein.